Skip to main content
. 2020 May 21;15(5):e0232679. doi: 10.1371/journal.pone.0232679

Fig 5. FLG2Nter activates SASPase proteolytic activity in vitro.

Fig 5

An in vitro enzymatic assay using recombinant proteins of 28 kDa SASPase (0.5 μM), and FLG2Nter (aa 2–213) and FLG2Nter (aa 81–213) at different mass ratios to SASPase 28 in the presence of a fluorescent-labeled peptide Dabcyl-QIDRIMEK-Glu(Edans)-NH2 (0.1 mM). The histogram presents the mean values (+/-SD) of each assay performed in triplicate.